Lexicon Pharmaceuticals | Der Umsatz

Sales Veränderung Datum
Abbott USD 9.96B 281M 2024-03
Acadia Pharmaceuticals USD 205.8M 25.24M 2024-03
Agios Pharmaceuticals USD 8.19M 1.09M 2024-03
Alnylam Pharmaceuticals USD 494.33M 54.61M 2024-03
AstraZeneca USD 12.02B 532M 2023-12
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Eli Lilly USD 8.77B 583.4M 2024-03
Halozyme Therapeutics USD 196M 34.04M 2024-03
Illumina USD 1.08B 42M 2024-03
Insmed USD 75.5M 8.19M 2024-03
Ironwood Pharmaceuticals USD 47.87M 69.68M 2024-03
J&J USD 21.38B 15M 2024-03
MacroGenics USD 10.72M 323K 2023-12
MannKind USD 66.26M 15.01M 2024-03
Merck USD 15.8B 1.17B 2024-03
Moderna USD 167B 164.19B 2024-03
Novartis USD 11.83B 54M 2024-03
PTC Therapeutics USD 210.12M 96.94M 2024-03
Sarepta Therapeutics USD 413.5M 16.72M 2024-03
Thermo Fisher Scientific USD 10.34B 546M 2024-03
Ultragenyx Pharmaceutical USD 108.8M 18.59M 2024-03
United Therapeutics USD 677.7M 63M 2024-03



Lexicon Pharmaceuticals Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2024.